Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Research and Innovation Action · Running

AISym4MED Synthetic and scalable data platform for medical empowered AI

Coordinator
Associacao Fraunhofer Portugal Research, Portugal
Runs
1 December 2022 to 30 November 2026
Status
Running
EU funding
€6.3m
Total cost
€6.3m
Partners
16 organisations in 8 countries
Type
Research and Innovation Action
Grant agreement
101095387

What the project is doing

In the project's own words, from its summary on CORDIS.

AISym4Med aims at developing a platform that will provide healthcare data engineers, practitioners, and researchers access to a trustworthy dataset system augmented with controlled data synthesis for experimentation and modeling purposes. This platform will address data privacy and security by combining new anonymization techniques, attribute-based privacy measures, and trustworthy tracking systems. Moreover, data quality controlling measures, such as unbiased data and respect to ethical norms, context-aware search, and human-centered design for validation purposes will also be implemented to guarantee the representativeness of the synthetic data generated.

Indeed, an augmentation module will be responsible for exploring and developing further the techniques of creating synthetic data, also dynamically on demand for specific use cases. Furthermore, this platform will exploit federated technologies for reproducing un-indentifiable data from closed borders, promoting the indirect assessment of a broader number of databases, while respecting the privacy, security, and GDPR-compliant guidelines.

The proposed framework will support the development of innovative unbiased AI-based and distributed tools, technologies, and digital solutions for the benefit of researchers, patients, and providers of health services, while maintaining a high level of data privacy and ethical usage. AISym4Med will help in the creation of more robust machine learning (ML) algorithms for real-world readiness, while considering the most effective computation configuration.

Furthermore, a machine-learning meta-engine will provide information on the quality of the generalized model by analyzing its limits and breaking points, contributing to the creation of a more robust system by supplying on-demand real and/or synthetic data. This platform will be validated against local, national, and cross-border use-cases for both data engineers, ML developers, and aid for clinicians’ operations.

Topics

Who is involved

OrganisationCityCountryRole
Associacao Fraunhofer Portugal ResearchPortoPortugalCoordinator
TimelexBruxelles / BrusselBelgiumParticipant
Zabala BrusselsBruxelles / BrusselBelgiumParticipant
Universitat ZurichZurichSwitzerlandAssociatedpartner
Asociacion Instituto De Investigacion Sanitaria BiobizkaiaBarakaldo BizkaiaSpainParticipant
Ayesa Ibermatica SASan Sebastian GuipuzcoaSpainParticipant
Consorcio Sanitario De L'alt Penedes Y Garraf (csapg)Vilafranca Del PenedesSpainParticipant
Instrumentacion Y Componentes SAZaragozaSpainParticipant
Servicio Vasco de Salud OsakidetzaVitoria-GasteizSpainThird party
Zabala Innovation Consulting SAMutilva Alta NavarraSpainThird party
Saidot OyEspooFinlandParticipant
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant
Nova Id Fct - Associacao Para a Inovacao E Desenvolvimento Da FctCaparicaPortugalParticipant
Universidade Do PortoPortoPortugalParticipant
Tiga Bilgi Teknolojileri Anonim SirketiGolbasiTürkiyeParticipant
Imperial College of Science Technology and MedicineLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI